Repligen Corp. buy Royal Bank of Canada
Start price
21.02.25
/
50%
€152.05
Target price
21.02.26
€195.98
Performance (%)
-33.48%
Price
15:15
€101.15
Summary
This prediction is currently active. The BUY prediction by Royal_Bank_of_Canada for Repligen Corp. is performing very badly with a performance of -33.48%. This prediction currently runs until 21.02.26. The prediction end date can be changed by Royal_Bank_of_Canada at any time. Royal_Bank_of_Canada has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Repligen Corp. | -0.676% | -0.676% |
| iShares Core DAX® | -0.172% | -1.333% |
| iShares Nasdaq 100 | 0.791% | 0.826% |
| iShares Nikkei 225® | 4.883% | 5.161% |
| iShares S&P 500 | 0.580% | 2.254% |
Comments by Royal_Bank_of_Canada for this prediction
In the thread Repligen Corp. diskutieren
Repligen Co. (NASDAQ: RGEN) had its price target raised by analysts at Royal Bank of Canada from $203.00 to $205.00. They now have an "outperform" rating on the stock.
Ratings data for RGEN provided by MarketBeat
Stopped prediction by Royal_Bank_of_Canada for Repligen Corp.
Repligen Corp.
Start price
Target price
Perf. (%)
€154.80
31.07.24
31.07.24
€175.54
31.07.25
31.07.25
-34.59%
01.08.25
01.08.25
Repligen Corp.
Start price
Target price
Perf. (%)
€157.00
06.09.23
06.09.23
€178.01
06.09.24
06.09.24
-14.68%
07.09.24
07.09.24